# EDARAVONE
> **ANDA217565** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2024-10-31
## Drug
- **FDA Application Number:** ANDA217565
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EDARAVONE
- **Generic name:** EDARAVONE
- **Active ingredients:** EDARAVONE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **Manufacturer:** XGen Pharmaceuticals DJB, Inc.
- **First approval:** 2024-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217565)
---
*MORVS · CC0 1.0*